| Trial ID: | L3678 |
| Source ID: | NCT01101269
|
| Associated Drug: |
Acei Or Arb
|
| Title: |
Effect of Angiotensin Converting Enzyme Inhibitor, Lisinopril, on Renal Blood Flow and Its Correlation With Proteinuria Reduction in Subjects With Type 2 Diabetes and Kidney Disease
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: ACEI or ARB|DRUG: Lisinopril
|
| Outcome Measures: |
Primary: Change in renal blood flow (RBF), We will use Contrast Enhanced Ultrasound using Definity as the contrast agent to monitor changes in renal blood flow (RBF)., Study day 10|Change in renal blood flow (RBF), Compared to Study Day 17 | Secondary: Change in Proteinuria, Study day 10|Change in Proteinuria, Compared to study day 17
|
| Sponsor/Collaborators: |
Sponsor: University of Virginia
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
6
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2010-02
|
| Completion Date: |
2014-12
|
| Results First Posted: |
|
| Last Update Posted: |
2017-05-12
|
| Locations: |
University of Virginia Health System, Charlottesville, Virginia, 22908, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT01101269
|
